Endothelin-Receptor Blockade in Coronary Heart Disease
NCT00427232
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
26
Enrollment
OTHER
Sponsor class
Conditions
Coronary Vessels
Endothelins
Vascular Resistance
Interventions
DRUG:
BQ-123 and BQ-788
Sponsor
Medical University of Vienna